Bohai Pharmaceuticals Group Inc (BOPH) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
C/O YANTAI BOHAI PHARMACEUTICALS GROUP YANTAI, SHANDONG PROVINCE, 264000 |
| State of Incorp. | NV |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2014 MRQ | 6/30/2014 | 6/30/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 23,309 | 6,948 | |||
| Cash and cash equivalents | 23,309 | 6,948 | |||
| Restricted cash and investments | 12,623 | ||||
| Receivables | 38,716 | ||||
| Inventory, net of allowances, customer advances and progress billings | 4,501 | 2,782 | |||
| Inventory | 4,501 | 2,782 | |||
| Other undisclosed current assets | 42,186 | 13,073 | |||
| Total current assets: | 82,619 | 61,519 | |||
| Noncurrent Assets | |||||
| Inventory, Noncurrent | 4,501 | ||||
| Property, plant and equipment | 21,128 | 17,678 | |||
| Intangible assets, net (including goodwill) | 80,744 | 57,175 | |||
| Goodwill | 5,223 | 5,202 | |||
| Intangible assets, net (excluding goodwill) | 75,521 | 51,973 | |||
| Deferred tax assets, net | 8,144 | ||||
| Other undisclosed noncurrent assets | (12,369) | 29,252 | |||
| Total noncurrent assets: | 102,148 | 104,105 | |||
| TOTAL ASSETS: | 184,766 | 165,624 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,633 | 19,490 | |||
| Interest and dividends payable | 2,373 | ||||
| Taxes payable | 3,086 | 2,222 | |||
| Employee-related liabilities | 456 | ||||
| Accounts payable | 5,082 | ||||
| Accrued liabilities | 15,719 | 12,186 | |||
| Debt | 4,873 | 8,465 | |||
| Other undisclosed current liabilities | 13,080 | 16,232 | |||
| Total current liabilities: | 39,586 | 44,187 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 8,048 | ||||
| Deferred tax liabilities, net | 8,048 | ||||
| Other undisclosed noncurrent liabilities | 15,580 | 5,000 | |||
| Total noncurrent liabilities: | 15,580 | 13,048 | |||
| Total liabilities: | 55,166 | 57,235 | |||
| Equity | |||||
| Equity, attributable to parent | 129,601 | 108,390 | |||
| Common stock | 18 | 18 | |||
| Additional paid in capital | 24,822 | 24,615 | |||
| Accumulated other comprehensive income | 8,114 | 9,000 | |||
| Retained earnings | 96,646 | 74,757 | |||
| Total equity: | 129,601 | 108,390 | |||
| TOTAL LIABILITIES AND EQUITY: | 184,766 | 165,624 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2014 TTM | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Revenues | 175,086 | 151,793 | ||
| Revenue, net | 151,793 | |||
| Cost of revenue | (42,376) | (38,208) | ||
| Cost of goods and services sold | (38,208) | |||
| Other undisclosed gross profit | 1,011 | |||
| Gross profit: | 132,710 | 114,596 | ||
| Operating expenses | (100,299) | (87,718) | ||
| Operating income: | 32,411 | 26,878 | ||
| Nonoperating income (expense) | 545 | (734) | ||
| Investment income, nonoperating | 184 | 39 | ||
| Loss, foreign currency transaction, before tax | (885) | |||
| Other nonoperating income (expense) | 1,247 | (17) | ||
| Interest and debt expense | 2,287 | (1,968) | ||
| Income from continuing operations before equity method investments, income taxes: | 35,243 | 24,176 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (3,688) | 1,968 | ||
| Income from continuing operations before income taxes: | 31,555 | 26,144 | ||
| Income tax expense (benefit) | 9,666 | (7,020) | ||
| Income from continuing operations: | 41,221 | 19,124 | ||
| Income before gain (loss) on sale of properties: | 41,221 | 19,124 | ||
| Net income: | 41,221 | 19,124 | ||
| Other undisclosed net loss attributable to parent | (19,332) | |||
| Net income available to common stockholders, basic: | 21,889 | 19,124 | ||
| Other undisclosed net income available to common stockholders, diluted | 583 | 1,069 | ||
| Net income available to common stockholders, diluted: | 22,472 | 20,193 | ||
Comprehensive Income ($ in thousands)
| 9/30/2014 TTM | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Net income: | 41,221 | 19,124 | ||
| Comprehensive income: | 41,221 | 19,124 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (20,218) | 2,764 | ||
| Comprehensive income, net of tax, attributable to parent: | 21,004 | 21,887 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.